William Schmidt

William Schmidt

Directeur Technique/Scientifique/R&D chez ENSYSCE BIOSCIENCES, INC.
75 ans
Health Technology
Consumer Services
Commercial Services

Profil

William K.
Schmidt
currently works at Signature Therapeutics, Inc., as Chief Medical Officer, Northstar Consulting Group, as President, and Ensysce Biosciences, Inc., as Chief Medical Officer.
Dr. Schmidt also formerly worked at Adolor Corp., as Vice President-Scientific Affairs, Renovis, Inc., as Vice President-Clinical Research, CG Invites Co., Ltd., as Vice President-Clinical Development, Limerick BioPharma, Inc., as Senior Vice President-Development, The Eastern Pain Association, as President, CG Pharmaceuticals, Inc., as Vice President-Clinical Development, and Arcion Therapeutics LLC, as Vice President-Clinical & Regulatory.
Dr. Schmidt received his undergraduate degree from the University of California, Berkeley and doctorate degree from The University of California, San Francisco.

Postes actifs de William Schmidt

SociétésPosteDébut
ENSYSCE BIOSCIENCES, INC. Directeur Technique/Scientifique/R&D -
President -
Directeur Technique/Scientifique/R&D -

Anciens postes connus de William Schmidt

SociétésPosteFin
CG INVITES CO., LTD. Corporate Officer/Principal -
CG Pharmaceuticals, Inc.
Corporate Officer/Principal -
President -
Directeur Technique/Scientifique/R&D -
Corporate Officer/Principal -
Voir l'expérience en détail de William Schmidt

Formation de William Schmidt

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

3

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

CG Pharmaceuticals, Inc.

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. William Schmidt
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT